Tenet Healthcare Free Cash Flow (FCF) History (THC)
Tenet Healthcare reported $2.53B in free cash flow for fiscal 2025, an increase of 126.70% from the previous fiscal year, with a free cash flow margin of 11.87%.
View full Tenet Healthcare company overviewTenet Healthcare free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.53B | $1.41B | +126.70% | +11.87% |
| 2024 | 2024-12-31 | $1.12B | −$507.0M | −31.24% | +5.40% |
| 2023 | 2023-12-31 | $1.62B | $1.30B | +405.61% | +7.89% |
| 2022 | 2022-12-31 | $321.0M | −$589.0M | −64.73% | +1.67% |
| 2021 | 2021-12-31 | $910.0M | −$1.96B | −68.26% | +4.67% |
| 2020 | 2020-12-31 | $2.87B | $2.30B | +409.24% | +16.25% |
| 2019 | 2019-12-31 | $563.0M | $131.0M | +30.32% | +3.05% |
| 2018 | 2018-12-31 | $432.0M | −$61.0M | −12.37% | +2.36% |
| 2017 | 2017-12-31 | $493.0M | $810.0M | — | +2.39% |
| 2016 | 2016-12-31 | −$317.0M | −$501.0M | — | −1.50% |
| 2015 | 2015-12-31 | $184.0M | $430.0M | — | — |
| 2014 | 2014-12-31 | −$246.0M | −$144.0M | — | — |
| 2013 | 2013-12-31 | −$102.0M | −$189.0M | — | — |
| 2012 | 2012-12-31 | $87.0M | $57.0M | +190.00% | — |
| 2011 | 2011-12-31 | $30.0M | — | — | — |
Tenet Healthcare quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $417.0M | −$326.0M | −43.88% | +7.41% |
| Q1 2026 | 2026-03-31 | $1.46B | $819.0M | +127.57% | +27.22% |
| Q4 2025 | 2025-12-31 | $367.0M | $1.03B | — | +6.64% |
| Q3 2025 | 2025-09-30 | $778.0M | −$51.0M | −6.15% | +14.71% |
| Q2 2025 | 2025-06-30 | $743.0M | $141.0M | +23.42% | +14.10% |
| Q1 2025 | 2025-03-31 | $642.0M | $296.0M | +85.55% | +12.29% |
| Q4 2024 | 2024-12-31 | −$661.0M | −$1.28B | — | −13.03% |
| Q3 2024 | 2024-09-30 | $829.0M | $502.0M | +153.52% | +16.17% |
| Q2 2024 | 2024-06-30 | $602.0M | $136.0M | +29.18% | +11.79% |
| Q1 2024 | 2024-03-31 | $346.0M | $132.0M | +61.68% | +6.45% |
| Q4 2023 | 2023-12-31 | $616.0M | $485.0M | +370.23% | +11.42% |
| Q3 2023 | 2023-09-30 | $327.0M | $177.0M | +118.00% | +6.45% |
| Q2 2023 | 2023-06-30 | $466.0M | $499.0M | — | +9.17% |
| Q1 2023 | 2023-03-31 | $214.0M | $141.0M | +193.15% | +4.26% |
| Q4 2022 | 2022-12-31 | $131.0M | $78.0M | +147.17% | +2.63% |
| Q3 2022 | 2022-09-30 | $150.0M | −$171.0M | −53.27% | +3.12% |
| Q2 2022 | 2022-06-30 | −$33.0M | −$156.0M | — | −0.71% |
| Q1 2022 | 2022-03-31 | $73.0M | −$340.0M | −82.32% | +1.54% |
| Q4 2021 | 2021-12-31 | $53.0M | −$227.0M | −81.07% | +1.09% |
| Q3 2021 | 2021-09-30 | $321.0M | −$186.0M | −36.69% | +6.56% |
| Q2 2021 | 2021-06-30 | $123.0M | −$2.01B | −94.23% | +2.48% |
| Q1 2021 | 2021-03-31 | $413.0M | $466.0M | — | +8.64% |
| Q4 2020 | 2020-12-31 | $280.0M | −$62.0M | −18.13% | +5.70% |
| Q3 2020 | 2020-09-30 | $507.0M | $244.0M | +92.78% | +11.13% |
| Q2 2020 | 2020-06-30 | $2.13B | $1.99B | +1423.57% | +58.47% |
| Q1 2020 | 2020-03-31 | −$53.0M | $129.0M | — | −1.17% |
| Q4 2019 | 2019-12-31 | $342.0M | $305.0M | +824.32% | +7.12% |
| Q3 2019 | 2019-09-30 | $263.0M | $61.0M | +30.20% | +5.76% |
| Q2 2019 | 2019-06-30 | $140.0M | −$83.0M | −37.22% | +3.07% |
| Q1 2019 | 2019-03-31 | −$182.0M | −$152.0M | — | −4.00% |
| Q4 2018 | 2018-12-31 | $37.0M | −$239.0M | −86.59% | +0.80% |
| Q3 2018 | 2018-09-30 | $202.0M | $38.0M | +23.17% | +4.50% |
| Q2 2018 | 2018-06-30 | $223.0M | $158.0M | +243.08% | +4.95% |
| Q1 2018 | 2018-03-31 | −$30.0M | −$18.0M | — | −0.64% |
| Q4 2017 | 2017-12-31 | $276.0M | $830.0M | — | — |
| Q3 2017 | 2017-09-30 | $164.0M | $96.0M | +141.18% | +3.32% |
| Q2 2017 | 2017-06-30 | $65.0M | −$165.0M | −71.74% | +1.26% |
| Q1 2017 | 2017-03-31 | −$12.0M | $49.0M | — | — |
| Q4 2016 | 2016-12-31 | −$554.0M | −$469.0M | — | — |
| Q3 2016 | 2016-09-30 | $68.0M | −$207.0M | −75.27% | — |
| Q2 2016 | 2016-06-30 | $230.0M | −$5.0M | −2.13% | — |
| Q1 2016 | 2016-03-31 | −$61.0M | $180.0M | — | — |
| Q4 2015 | 2015-12-31 | −$85.0M | −$105.0M | — | — |
| Q3 2015 | 2015-09-30 | $275.0M | $265.0M | +2650.00% | — |
| Q2 2015 | 2015-06-30 | $235.0M | $211.0M | +879.17% | — |
| Q1 2015 | 2015-03-31 | −$241.0M | $59.0M | — | — |
| Q4 2014 | 2014-12-31 | $20.0M | $58.0M | — | — |
| Q3 2014 | 2014-09-30 | $10.0M | −$54.0M | −84.38% | — |
| Q2 2014 | 2014-06-30 | $24.0M | −$13.0M | −35.14% | — |
| Q1 2014 | 2014-03-31 | −$300.0M | −$135.0M | — | — |
| Q4 2013 | 2013-12-31 | −$38.0M | $207.0M | — | — |
| Q3 2013 | 2013-09-30 | $64.0M | −$70.0M | −52.24% | — |
| Q2 2013 | 2013-06-30 | $37.0M | −$205.0M | −84.71% | — |
| Q1 2013 | 2013-03-31 | −$165.0M | −$121.0M | — | — |
| Q4 2012 | 2012-12-31 | −$245.0M | — | — | — |
| Q3 2012 | 2012-09-30 | $134.0M | — | — | — |
| Q2 2012 | 2012-06-30 | $242.0M | — | — | — |
| Q1 2012 | 2012-03-31 | −$44.0M | — | — | — |
Tenet Healthcare free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $2.87B to $2.53B, a compound annual decline of 2.47%. Tenet Healthcare's latest reported quarter, Q2 2026, generated $417.0M in free cash flow, a decrease of 43.88% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Tenet Healthcare filings at SEC.gov ↗